Epitopix Revenue and Competitors
Estimated Revenue & Valuation
- Epitopix's estimated annual revenue is currently $35M per year.
- Epitopix's estimated revenue per employee is $583,333
Employee Data
- Epitopix has 60 Employees.
Epitopix Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | N/A | 12 | -14% | N/A | N/A |
#2 | $1.7M | 28 | -28% | N/A | N/A |
#3 | $35M | 60 | N/A | N/A | N/A |
#4 | $3.5M | 37 | 12% | N/A | N/A |
#5 | $15M | 165 | 23% | N/A | N/A |
#6 | $35M | 504 | 8% | N/A | N/A |
#7 | $15M | 302 | 6% | N/A | N/A |
#8 | N/A | 30 | 11% | N/A | N/A |
#9 | N/A | 34 | 3% | N/A | N/A |
#10 | $3.5M | 62 | 7% | N/A | N/A |
What Is Epitopix?
Epitopix owns intellectual property rights to key technologies, including SRP® Technology, involving the production of highly efficacious and safe veterinary vaccines. Epitopix performs discovery, research and development, and manufacturing of these technologies. Epitopix holds a USDA Establishment License No. 365 for the manufacture of licensed veterinary biologicals.
keywords:N/A
N/A
Total Funding
60
Number of Employees
$35M
Revenue (est)
N/A
Employee Growth %
N/A
Valuation
N/A
Accelerator
Epitopix's People
| Name | Title | Email/Phone |
|---|---|---|
1 | Chief Science Officer/Dir Discovery | Reveal Email/Phone |
2 | Senior Administrator | Reveal Email/Phone |
3 | Director Manufacturing | Reveal Email/Phone |
Epitopix News
... Gallant Custom Laboratories, CevaBiovac, Dyntecs.r.o., UVAXX, Deltamune, Epitopix, Genova Labs., Hygieia Biological Laboratories.
Vaxxinova, Newport Laboratories Inc, Gallant Custom Laboratories, CevaBiovac, Dyntecs.r.o., UVAXX, Deltamune, Epitopix, Genova Labs.,...
Council members also gave their permission for the street and parking lot overlay projects and the Epitopix water and sanitary sewer...
Other Companies in Willmar
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $7.5M | 60 | -2% | N/A |
#2 | $7.5M | 73 | 4% | N/A |
#3 | $20.5M | 76 | 15% | N/A |
#4 | $13.4M | 82 | 0% | N/A |
#5 | N/A | 89 | 46% | N/A |